Development of the first national reference substance of favipiravir as a candidate drug against COVID-19
XIONG Jing, YAN Jing, LIU Yi, LIU Yang, HE Lan
Chinese Journal of Pharmacovigilance . 2022, (1): 52 -56 .  DOI: 10.19803/j.1672-8629.2022.01.11